Quantcast

Latest Retinopathy Stories

2014-08-26 16:28:14

LONDON, Aug. 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Diabetic Retinopathy Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/diabetic_retinopathy_global_clinical_trials_review.htmlDiabetic Retinopathy Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Diabetic Retinopathy Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Retinopathy...

2014-08-07 23:04:10

Global Retinal Vein Occlusion Market 2014-2018 analyzes key players like Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG and Regeneron Pharmaceuticals Inc., Alimera Sciences, Bristol-Myers Squibb, NicOx, Santen Pharmaceutical and Valeant Pharmaceuticals. Dallas, Texas (PRWEB) August 07, 2014 One of the growth-pertaining trends in the market is the introduction of biologics as a treatment option for retinal vein occlusion. Drugs such as Avastin (bevacizumab) and Lucentis (ranibizumab),...

2014-08-05 12:25:50

LONDON, Aug. 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:U.S. Market and Survey for Retinopathy Screening Deviceshttp://www.reportbuyer.com/pharma_healthcare/diseases/u_s_market_survey_retinopathy_screening_devices.htmlAbstract:The market for diabetic retinopathy screening devices is in its infancy. Growth is expected under all forecast scenarios; however, the rate of growth will be determined by pricing and reimbursement. Several different...

2014-07-30 08:33:22

DUBLIN, July 30, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Retinal Vein Occlusion Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 Retinal vein occlusion is a medical condition where there is a blockage in the retinal veins. This blocks the flow of blood in the retina, which can damage the nerve cells of the eye and result in loss of vision. Retinal vein occlusion can occur as a result of a clot in a...

2014-07-14 23:03:57

The Retina Group of New York (RGONY), with offices in Hicksville and Hauppauge, NY, has announced the availability of Ozurdex® (dexamethasone intravitreal implant) as a long-lasting treatment for diabetic macular edema (DME) patients. Hicksville and Hauppauge, NY (PRWEB) July 14, 2014 The Retina Group of New York (RGONY), with offices in Hicksville and Hauppauge, NY, has announced the availability of Ozurdex® (dexamethasone intravitreal implant) as a long-lasting treatment for...

2014-05-28 12:30:11

MORGANTOWN, W.Va., May 28, 2014 /PRNewswire/ -- The Eye Foundation of America announced today that it is working with the Gourami Eye Institute, a fully-equipped eye hospital in Rajahmundry, India (300 miles east of Hyderabad) to provide international learning opportunities for ophthalmology students who have an interest in diabetic retinopathy. The program will provide students hands-on experience performing in-the-field diabetic retinopathy preventative screenings as well as...

2014-05-12 11:53:53

Lunenfeld-Tanenbaum Research Institute Bioengineering a safe treatment for retinopathy, the leading cause of vision loss in Canada A new drug approach has been developed for safer clean-up of deformed blood vessels in the eye by a research team at the Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital in Toronto. The growth of malformed blood vessels that can burst is a leading cause of vision loss in North America. Retinopathy and retina degeneration are associated with...

2014-04-28 08:30:58

-- Intravitreal corticosteroid implant for treatment of vision impairment associated with diabetic macular oedema MELBOURNE, Australia and ATLANTA, April 28, 2014 /PRNewswire/ -- Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia (STA) and Alimera Sciences (NASDAQ: ALIM). The exclusive...

2014-04-17 15:26:52

Indiana University researchers have detected new early-warning signs of the potential loss of sight associated with diabetes. This discovery could have far-reaching implications for the diagnosis and treatment of diabetic retinopathy, potentially impacting the care of over 25 million Americans. "We had not expected to see such striking changes to the retinas at such early stages," said Ann Elsner, professor and associate dean in the IU School of Optometry and lead author of the study. "We...

2014-04-01 16:25:30

Welch brings more than 25 years of leadership and global healthcare industry expertise to IRIS as the company expands its regional and national footprint PENSACOLA, Fla., April 1, 2014 /PRNewswire/ -- IRIS: Intelligent Retinal Imaging Systems, the country's preeminent cloud-based retinal screening technology provider, announced today that Pat Welch has joined its leadership team as Vice President of Healthcare Accounts. "Pat brings to the IRIS team more than 25 years of in-depth,...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related